Erespal: instructions for use of syrup, tablets. Erespal (syrup \ tablets): instructions for use, analogues and reviews, prices in Russian pharmacies Erespal is used for what

As well as additional substances: hypromellose, calcium hydrogen phosphate, macrogol 6000, silicon dioxide, povidone, titanium dioxide, magnesium stearate, .

Compound cough syrup next: active substance fenspiride hydrochloride , additional substances: flavor, glycerol, licorice extract, sunset yellow S, propyl parahydroxybenzoate, methyl parahydroxybenzoate, sucrose, saccharin, potassium sorbate, water.

Release form

  • Cough tablets have a white shell, in a pack of 30 pcs.
  • Syrup in 150 ml plastic bottles, it is an orange transparent liquid in which a precipitate may form. When shaking the vial, it disappears. The bottle is placed in a cardboard box.

Method of application of the drug - oral.

pharmachologic effect

According to Wikipedia, the remedy has an antispasmodic, antihistamine, anti-inflammatory effect.

Pharmacodynamics and pharmacokinetics

Erespal (Eurespal) prevents bronchoconstriction , slows down exudation . The anti-inflammatory effect that fenspiride , due to inhibition of the metabolism of arachidonic acid. Anti-bronchoconstrictor effect is produced due to inhibition of the process of release of biologically active substances: histamine , serotonin , bradykinin . In addition, the drug blocks α-adrenergic receptors, upon stimulation of which there is an increase in the production of bronchial secretions.

Before the ban price Erespal cough syrup 150 ml averaged 250-300 rubles. Price Erespal tablets was equal to about 400-500 rubles. for 30 tablets of 80 mg. The cost of tablets in Ukraine is approximately 120-140 UAH. for 30 tablets.

How much Erespal tablets or syrup cost in cities such as Odessa, Kharkov, you can find out exactly at specific points of sale.

Laboratories Servier Industry Laboratories Servier Industry / Serdiks, LLC Laboratories Servier / Laboratories Servier Industry Serdiks, OOO Pharmstandard-Leksredstva OAO

Country of origin

Russia France France/Russia

Product group

Respiratory system

Drug with anti-inflammatory and anti-bronchoconstrictor activity

Release form

  • 15 - blisters (2) - packs of cardboard. upak 30 tablets bottle 150 ml bottle 250 ml in cards. pack

Description of the dosage form

  • Syrup Syrup orange, clear; possible formation of a precipitate that disappears when shaken Tablets, film-coated white, round, biconvex. film-coated tablets

pharmachologic effect

The anti-inflammatory and anti-bronchoconstrictor activity of fenspiride is due to a decrease in the production of a number of biologically active substances (cytokines, especially tumor necrosis factor alpha (TNF-alpha), arachidonic acid derivatives, free radicals), which play an important role in the development of inflammation and bronchospasm. Inhibition of arachidonic acid metabolism by fenspiride is potentiated by its H1-antihistamine action, tk. histamine stimulates the metabolism of arachidonic acid with the formation of prostaglandins and leukotrienes. Fenspiride blocks alpha-adrenergic receptors, the stimulation of which is accompanied by an increase in the secretion of bronchial glands. Thus, fenspiride reduces the effect of a number of factors that contribute to the hypersecretion of pro-inflammatory factors, the development of inflammation and bronchial obstruction. Fenspiride also has an antispasmodic effect.

Pharmacokinetics

Well absorbed from the gastrointestinal tract. The maximum plasma concentration after oral administration is reached after 2.3 ± 2.5 hours (from 0.5 to 8 hours). The half-life is 12 hours. It is excreted mainly by the kidneys (90%), through the intestines 10%.

Special conditions

The composition of the drug in the form of a syrup includes parabens (parahydroxybenzoates), as a result, taking this drug can provoke the development of allergic reactions, incl. delayed. When prescribing the drug to patients with diabetes, it should be taken into account that Erespal® syrup contains sucrose (1 teaspoon - 3 g of sucrose = 0.3 XE; 1 tablespoon - 9 g of sucrose = 0.9 XE). Influence on the ability to drive vehicles and control mechanisms Studies on the effect of the drug Erespal® on the ability to drive vehicles and work with mechanisms have not been conducted. Patients should be aware of the possible development of drowsiness when taking Erespal®, especially at the beginning of therapy or when combined with alcohol intake, and should be careful when driving vehicles and performing work that requires a high speed of psychomotor reactions. Overdose In case of an overdose of the drug (there have been cases of overdose when taking the drug at a dose of more than 2320 mg), the patient should immediately seek medical help. Symptoms: drowsiness or agitation, nausea, vomiting, sinus tachycardia. Treatment: gastric lavage, ECG monitoring, maintenance of vital body functions.

Compound

  • 1 tab. Fenspiride hydrochloride 80 mg Excipients: calcium hydrogen phosphate, hypromellose, povidone, anhydrous colloidal silicon dioxide, magnesium stearate. The composition of the film shell: titanium dioxide, glycerol, hypromellose, macrogol 6000, magnesium stearate. 100 ml fenspiride hydrochloride 200 mg Excipients: flavoring composition with hints of honey smell - 500 mg, licorice root extract - 200 mg, vanilla tincture - 400 mg, glycerol - 22.5 g, sunset yellow dye (sunset yellow S) - 10 mg, methyl parahydroxybenzoate - 90 mg, propyl parahydroxybenzoate - 35 mg, saccharin - 45 mg, sucrose - 60 mg, potassium sorbate - 190 mg, purified water - up to 100 ml. fenspiride hydrochloride - 0.2 g. Excipients: flavoring composition with hints of honey smell 0.500 g, licorice root extract 0.200 g, vanilla tincture 0.400 g, glycerol 22.5 g, sunset yellow dye (Sunset yellow S) 0.01 g , methyl parahydroxybenzoate 0.09 g, propyl parahydroxybenzoate 0.035 g; saccharin 0.045 g, sucrose 60.0 g, potassium sorbate 0.19 g; purified water up to 100 ml

Erespal indications for use

  • Diseases of the upper and lower respiratory tract: - nasopharyngitis and laryngitis; - tracheobronchitis; - bronchitis (with or without chronic respiratory failure); - bronchial asthma (as part of complex therapy); - respiratory phenomena (cough, hoarseness, sore throat) with measles, whooping cough, influenza; - infectious diseases of the respiratory tract, accompanied by a cough, when standard antibiotic therapy is indicated. Otitis and sinusitis of various etiologies.

Overdose

Symptoms: drowsiness or agitation, nausea, vomiting, sinus tachycardia. Treatment: gastric lavage, ECG monitoring, maintenance of vital body functions.

Storage conditions

  • keep away from children
Information provided

Hello my dears!

Welcome to my review!

I hope I can help someone and save them from the terrible consequences that Erespal causes.

If, nevertheless, it is not possible to avoid taking it, at least you will be aware of its negative impact and it will not be a shock for you, as it was in my case.

Someone will say, but not everyone has side effects from drugs? Yes, not everyone, but wandering around the Internet, I noticed that out of "about" 100 people who took Erespal, 80 had side effects.

Impressive right?

So let's go:

Choking and coughing, she went to the therapist, who diagnosed acute tracheitis.

I wrote out syrup and tea, for which I have no complaints, and Erispal was also on the list.

I ran to the pharmacy at a run. the state was terrible and there was no time to think.

Now I will describe the drug, the main thing from the instructions:

ERESPAL 80mg

Compound: 1 film-coated tablet contains Active substance: fenspiride hydrochloride - 80 mg. Excipients: calcium hydrophosphate 104.5 mg; hypromellose 100 mg; povidone 12.80 mg; silicon dioxide colloidal anhydrous 0.50 mg; magnesium stearate 2.20 mg; Shell: titanium dioxide 0.841 mg; glycerol 0.263 mg; hypromellose 4.370 mg; macrogol 6000 0.263 mg; magnesium stearate 0.263 mg.

Pharmacotherapeutic group Anti-inflammatory, anti-bronchoconstrictor agent.

PHARMACOLOGICAL PROPERTIES

Pharmacodynamics

The anti-inflammatory and anti-bronchoconstrictor activity of fenspiride is due to a decrease in the production of a number of biologically active substances (cytokines, especially tumor necrosis factor α (TNF-α), arachidonic acid derivatives, free radicals), which play an important role in the development of inflammation and bronchospasm. H1- antihistamine action, tk. histamine stimulates the metabolism of arachidonic acid with the formation of prostaglandins and leukotrienes. Fenspiride blocks α-adrenergic receptors, the stimulation of which is accompanied by an increase in the secretion of bronchial glands. Thus, fenspiride reduces the effect of a number of factors that contribute to the hypersecretion of pro-inflammatory factors, the development of inflammation and bronchial obstruction. Fenspiride also has an antispasmodic effect.

Pharmacokinetics Cmax after oral administration is reached after 6 hours. T½ -12 hours. Excreted mainly by the kidneys.

INDICATIONS Diseases of the upper and lower respiratory tract:

  • Rhinopharyngitis and laryngitis
  • Tracheobronchitis
  • Bronchitis (with or without chronic respiratory failure)
  • Bronchial asthma (as part of complex therapy)
  • Respiratory effects (cough, hoarseness, sore throat) with measles, whooping cough and influenza
  • For infectious diseases of the respiratory tract, accompanied by a cough, when standard antibiotic therapy is indicated
  • Otitis and sinusitis of various etiologies.

CONTRAINDICATIONS Hypersensitivity to the active substance and / or any of the components of the drug. Children under 18 years of age (Erespal ® syrup should be used to treat children and adolescents under 18 years of age).

PREGNANCY AND BREASTFEEDING Taking the drug during pregnancy is not recommended. Therapy with fenspiride is not a basis for terminating the onset of pregnancy. Clinical data on the fetotoxic effect of fenspiride or its ability to cause malformations when taken during pregnancy are absent. data on the penetration of fenspiride into breast milk.

METHOD OF APPLICATION AND DOSES Inside. Adults: 1 tablet 2-3 times a day. The maximum daily dose is 240 mg. The duration of treatment is determined by the doctor.

SIDE EFFECTINFORM YOUR DOCTOR ABOUT THE APPEARANCE OF ANY, INCLUDING, NOT MENTIONED IN THIS INSTRUCTIONS, ADVERSE REACTIONS AND FEELINGS, AND ALSO ABOUT CHANGES IN LABORATORY INDICATORS DURING THE BACKGROUND OF THERAPY.

The frequency of adverse reactions that may occur during therapy is given as the following gradation: very often (> 1/10); often (>1/100, 1/1000, 1/10000, From the side of the cardiovascular systemRarely: moderate tachycardia, the severity of which decreases with a decrease in the dose of the drug. From the digestive system:Often: gastrointestinal disorders, nausea, epigastric pain. Unset frequency: diarrhea, vomiting. From the side of the central nervous system:Rarely: drowsiness. Unset frequency: dizziness. General disorders and symptoms:Unset frequency: asthenia, increased fatigue. From the skin and subcutaneous fat:Rarely: erythema, rash, urticaria, angioedema, fixed erythema pigmentosa. Unset frequency: skin itching.

OVERDOSE In case of an overdose of the drug (cases of overdose have been noted when taking the drug at a dose of more than 2320 mg), you should immediately seek medical help. Symptoms: drowsiness or agitation, nausea, vomiting, sinus tachycardia. Treatment: gastric lavage, electrocardiogram (ECG) monitoring. Maintaining the vital functions of the body.

INTERACTION WITH OTHER DRUGS Special studies on the interaction of fenspiride with other drugs have not been conducted. Due to the possible increase in the sedative effect when taking histamine H1 receptor blockers, it is not recommended to use Erespal in combination with drugs that have a sedative effect, or in conjunction with alcohol.

SPECIAL INSTRUCTIONS For the treatment of children and adolescents under 18 years of age, Erespal ® syrup should be used. Studies on the effect of Erespal ® on the ability to drive vehicles and work with mechanisms have not been conducted. Patients should be aware of the possible development of drowsiness when taking Erespal®, especially at the beginning of therapy or when combined with alcohol intake, and should be careful when driving vehicles and performing work that requires a high speed of psychomotor reactions.

RELEASE FORM Film-coated tablets, 80 mg. 15 tablets per blister (PVC/Al). 2 blisters with instructions for medical use in a cardboard pack.

STORAGE CONDITIONS At a temperature not higher than 25 ° C. Keep out of the reach of children. List B.

BEST BEFORE DATE 3 years. DO NOT USE AFTER THE EXPIRY DATE STATED ON THE PACKAGING.

TERMS AND CONDITIONS OF DISCOUNT FROM PHARMACIES On prescription.

So,

I read the instructions only about how to take, although the doctor wrote 1 tablet 2 times a day.

Didn't even look at the side effects.


Sorry, the packaging is a little dirty.

MONDAY:

The first day of admission in the evening, everything is ok.

TUESDAY:

I've already taken it twice a day, everything seems to be fine.

WEDNESDAY:

Light dizziness and weakness began, appetite disappeared, and if you managed to eat something, heartburn and bitterness in your mouth began. There was a slight ache in the body, and even taking off and putting on some wardrobe items, the body felt like one big wound, as if the skin had been removed (these sensations lasted about a week).

I didn’t attach much importance when I get sick this happens.

THURSDAY:

The cough decreased, but weakness and drowsiness increased, as if she had not slept for a week.

But the most unexpected thing was when, while climbing the stairs to the second floor, she barely reached, shortness of breath appeared, but not from coughing, but there was a feeling that her heart was jumping out of her chest.

Also, when rising from a squat, his eyes turned black and there was a fainting state. And I had to squat and bend over all the time, because. small child, mothers will understand.

Here comes the worst day...

FRIDAY:

I woke up, everything seemed fine, I took a pill. Gathered, for work it was necessary to go behind the wheel, the time is about 11 am. Everything flew to one end in order, but back I was already a “vegetable”, my head was spinning, my eyes were closing and my heart was beating wildly. In general, I don’t remember well how I got home, since it was not far away.

I decided to stop taking Erespal.

I had lunch, I remind you, zero appetite, even a little sick.

The time is 14.00, I fall down and my eyes close.

An hour later we went to the dacha, it was quite hot, mid-August.

By the way, the drug still causes a feeling of anxiety, a funny story happened on the road.

Father is driving, mother is next to him, everyone else is behind. Mom and dad are generally quite reckless. The road runs through the forest and off-road, about 40 km. It is clear that off-road speed is not high, we eat and behind some car. But then the asphalt appeared and the father begins to break away from the car behind him, and he, too, began to catch up with the campaign.

It seems that they didn’t accelerate much, but I start to get hysterical, I scream don’t drive, there is a dangerous turn, we will all die :))) It’s funny to remember now, but then I was insanely scared, although I trust my father 100%.

Arriving, I sat down on the street, I don’t want to get up, because it seems that at the slightest movement the heart will jump out, and it was still stuffy in the house, the time was 22.00.

My head began to hurt a lot, the pressure was normal, I thought maybe because of the weather, although I am not weather dependent.

I go on the Internet and read about the side effects, people have one to one.

But two reviews were very strangled and frightened:

  1. In no case should Erespal be taken by people who often drive, because. you can fall asleep at any moment and not understand who you are and where you are.
  2. In one person, the pressure dropped to 60/40 HORROR, who does not understand, this is resuscitation or death.

To be honest, Friday night is a blur.

SATURDAY:

Tachycardia seems to have decreased, but weakness still persisted, I constantly wanted to sit down, then lie down.

Still no appetite. Squats are still given with a blackout in the eyes, but without seeming to faint.

The pressure jumps a little, then up, then down, but not significantly by 10 units.

General condition as a "vegetable".

On Friday and Saturday I drank a lot of water to cleanse the body faster.

SUNDAY:

Cheers cheers!!! I thought! The heart is in place, the head does not hurt or spin. Mom returned to the child, not "zombies". There is a slight weakness and body aches, but this is nonsense.

Oh, how wrong I was, after 14.00 it began to turn into a “vegetable” again.

The next week was more successful, but, but, but dizziness and slight weakness persisted, the pressure dropped 100/80 or 100/70, the general signs were similar to vegetative-vascular dystonia.

I go back to the Internet looking for information, indeed Erespal caused VVD in some people, and not as a temporary phenomenon, but on an ongoing basis.

Scared!!!

But thank God, everything returned to normal, not immediately, of course, but two weeks later, after the last dose.

MY CONCLUSION:

It is difficult to say whether this drug helped, the cough decreased and filth began to come out, but earlier it was the same without taking Erespal.

Search, ask for a replacement, and run away from him, unless it is a matter of life and death.

I will definitely not go to the doctor who prescribed Erespal for me, “BIG HELLO”.

Yes, perhaps she herself is to blame, but knowing Russian carelessness, he could at least warn.

By the way, there is also Erespal in the form of syrup, it is mainly prescribed for children. I read reviews of moms and they are very satisfied with his action. But having honestly gone through all this, if my child is ever prescribed this drug, I will refuse and will ask for a replacement.

I give the drug Erespal one star, only because during this painful week I lost 2 kilograms.

That's all!

I wish you all good health and avoid such mistakes, learn from strangers.

THANK YOU FOR YOUR ATTENTION!!!

See you soon!

Your Love!





Erespal (fenspiride) is a drug with a bronchodilatory and antispasmodic effect, which is often used in the complex therapy of bronchial asthma. It has a clinically proven ability to increase the activity of the cilia of the bronchial ciliated epithelium, normalize the volume of bronchial secretions and reduce its viscosity. Effectively relieves bronchial obstruction, restores pulmonary gas exchange.

  • Not recommended for the treatment of pregnant and lactating women. Children from 2 years of age can only be prescribed in the form of syrup.
  • Included in the list of essential drugs.
  • Available in two dosage forms for oral administration: syrup and tablets.

Pharmgroup

A drug with anti-bronchoconstrictor and anti-inflammatory activity.
Pharmacological group of the active substance of the drug (fenspiride): H1 antihistamines.

The composition of the drug

Active substance Excipients Shell

Pills

80 mg fenspiride hydrochloride 104.5 mg of calcium hydrogen phosphate, 100 mg of hypromellose, 0.5 mg of anhydrous colloidal silicon dioxide, 12.8 mg of povidone-K30, 2.2 mg of magnesium stearate. 0.841 mg titanium dioxide, 0.263 mg macrogol 6000, 0.263 mg glycerol, 0.263 mg magnesium stearate, 4.37 mg hypromellose.

Syrup

200 mg fenspiride hydrochloride (per 1 ml syrup -2 mg fenspiride) 500 mg honey flavor, 400 mg vanilla tincture, 200 mg licorice root extract, 10 mg Sunset S yellow, 90 mg methyl parahydroxybenzoate, 22.5 g glycerol, 60 mg sucrose, 45 mg saccharin, 35 mg propyl parahydroxybenzoate, 190 mg potassium sorbate, purified water up to a volume of 100 ml.

Release form, price

  • Erespal syrup: a clear liquid with an orange color, in brown plastic bottles of 150 or 250 ml, in a carton. Price:
    syrup 150 ml - 210-264 rubles,
    syrup 250 ml - 333-428 rubles.
  • Erespal tablets: white round biconvex film-coated tablets, 15 pieces in a blister, in a carton pack of 2 blisters (30 tablets).
    Price: 299-430 rubles.

pharmachologic effect

According to the instructions for the use of Erespal, the active ingredient of the drug - fenspiride - has a pronounced anti-inflammatory and anti-bronchoconstrictor effect, due to a decrease in the production of the main biologically active substances that play a key role in the development of the inflammatory reaction and bronchospasm: cytokines, free radicals, metabolites of arachidonic acid.

It inhibits the metabolism of arachidonic acid, simultaneously blocking histamine H1 receptors, since it is histamine that stimulates the chemical reactions of the conversion of arachidonic acid into final metabolites-inflammatory factors. Reduces the production of other inflammatory mediators - serotonin and bradykinin.

Blocks α-adrenergic receptors, the activation of which enhances the secretion of bronchial glands. The complex action of fenspiride reduces the pathological effect of a number of factors that promote hypersecretion of anti-inflammatory substances and cause obstruction of the bronchial tree. It has a pronounced antispasmodic and myotropic effect.

Pharmacokinetics

The drug is well absorbed in the gastrointestinal tract. Erespal's instructions indicate that after oral administration of 1 tablet, the maximum concentration of fenspiride in the blood is detected after 6 hours, the use of syrup determines the effective concentration after 2.5 hours. The half-life (T 1/2) is 12 hours, it is excreted mainly through the urinary system (up to 90%), a small part is excreted by the intestines (about 10%).

Indications for use

The drug is indicated in the complex therapy of diseases of the respiratory tract (upper and lower sections):

  • pharyngitis;
  • nasopharyngitis;
  • laryngitis;
  • tracheitis;
  • tracheobronchitis;
  • bronchitis (with or without chronic respiratory failure);
  • bronchial asthma;
  • respiratory symptoms in influenza, measles and whooping cough;
  • sinusitis;
  • otitis;
  • infections of the respiratory system, in the symptom complex of which there is a cough.

Contraindications

  • Hypersensitivity reactions to the main or excipients of the drug.
  • Tablets - up to 18 years
  • Syrup - children under 2 years old

Use in pregnant and lactating women

The use of Erespal during pregnancy and lactation is not recommended due to the limited clinical safety data for these categories of people. However, therapy with Erespal and analogues during the gestation period is not a basis for artificial termination of pregnancy.

Dosage

Syrup Erespal

Erespal tablets

Adults and teenagers over 18 years of age 45-90 milliliters (3-6 tablespoons, respectively) per day. 1 tablet (80 mg) twice or thrice a day. The maximum daily dose is 240 mg (3 tablets).
Children from 2 years old - at the rate of 4 mg per 1 kg of weight.

Children under 10 kg: 10-20 milliliters (2-4 teaspoons respectively) per day.

Children over 10 kg: 30-60 ml (2-4 tablespoons respectively) per day.

special instructions It is taken before meals. Be sure to shake before use. For young children, adding to a bottle with food or drink is acceptable. It is taken half an hour before meals with water.
Duration of treatment Determined by the doctor

Side effect

  • The main adverse reactions during therapy with Erespal are observed from the gastrointestinal tract: gastrointestinal disorders, pain in the epigastric region, nausea, vomiting, diarrhea and vomiting are somewhat less common.
  • From the side of the CCC, tachycardia, palpitations, a non-critical drop in blood pressure are possible.
  • From the side of the central nervous system, the development of drowsiness and dizziness is likely.
  • On the part of the skin: urticaria, erythema, angioedema, pruritus, epidermal necrolysis of a toxic nature.
  • General disorders: asthenic phenomena, increased fatigue.
  • Extra for syrup: Hypersensitivity reactions to Sunset Yellow S.

Overdose

When taking syrup or tablets in a dose of more than 2320 mg, contact a medical facility immediately. Symptoms: agitation or drowsiness, lethargy, nausea and vomiting, tachycardia with accelerated sinus rhythm.

drug interaction

Due to the possibility of developing an adverse reaction in the form of a sedative effect, it is not recommended to combine Erespal with drugs with sedative activity and alcohol.

special instructions

The presence of parabens in the composition of the syrup can provoke the development of allergic reactions (immediately after administration and delayed).

Patients with diabetes should take into account the presence of sucrose in the composition: in 1 tsp. - 3 g (0.3 XE), 1 tbsp. contains 9 g (0.9 XE).

During therapy with Erespal, due to possible sedative reactions, caution is required if it is necessary to drive vehicles, work with precise mechanisms and activities that require a high reaction rate.

Shelf life and storage

Valid for 3 years from date of manufacture. Does not require special storage conditions. During storage of the syrup, sedimentation is likely, which disappears when shaken and does not affect activity.

Erespal's analogs

Siresp, Eladon, Inspiron, Fosidal, Fenspiride.


Erespal is a well-known medicine for the treatment of diseases of the ENT organs. Erespal for adults is prescribed exclusively in the form of tablets, for children the drug is usually prescribed in syrup.

Composition and medicinal properties

Cough, as a sign of infectious diseases, indicates the development of inflammation in the lower respiratory organs. The accumulation and stagnation of sputum lead to a feeling of heaviness in the chest, pain, as well as a strong sore throat.

To reduce coughing attacks and extract mucus, specialists prescribe various means of antitussive and expectorant effects. Erespal, unlike other medicines, acts purposefully, eliminating the cause of cough - an inflammatory process.

The product is produced in the form of tablets of 80 mg, as well as in the form of a syrup of 150 ml. In childhood, a liquid form is used, which additionally contains flavors, licorice, sucrose, and is easily absorbed by the child's body.

In addition to anti-inflammatory properties, the tool has the following abilities:

  • relieves swelling of mucous surfaces;
  • prevents narrowing of the lumen of the bronchi;
  • thins viscous mucus.

The active ingredient of the drug is fenspiride, which has a bronchodilatory and anti-inflammatory effect. In addition to the main ingredient, the tablets also include:

  • calcium hydrophosphate;
  • hypromellose;
  • stearic acid;
  • silicon dioxide.

Due to the complex action on the organs of the respiratory system, the drug not only effectively relieves spasms of smooth muscles, relaxing and expanding the bronchi, but also exhibits antitussive qualities. It is these properties that make it possible to use it in the treatment of unproductive cough.

How it works

Erespal is a unique medication that prevents the spread of the inflammatory process in a short time and has bronchodilator properties.

The drug blocks mediators of the inflammatory process, removing not only the symptoms of the disease, but also its root cause, acting directly in the focus of inflammation.

The drug affects the activation of the ciliated epithelium, normalizes gas exchange in the lung tissues, stimulating the thinning of mucus.

Fenspiride blocks histamine receptors, inhibits the production of arachidonic acid, which plays an important role in the appearance of edema, bronchospasm and sputum hyperproduction.

Thus, the tool acts in several directions:

  • helps to reduce the clinical manifestations of infectious diseases - relieves swelling of the mucous membranes, relieves pain symptoms in the throat, cough and runny nose;
  • affects the focus of the inflammatory process;
  • restores nasal breathing;
  • does not require intensive concomitant treatment;
  • practically does not provoke allergic reactions;
  • can be combined with other agents without reducing their therapeutic efficacy;
  • shortens the period of illness, accelerating the cure;
  • can be administered to young children from 2 years.

When taken orally, the drug in tablets reaches its highest concentration after 6 hours, in syrup - after 3 hours. 12 hours after ingestion, the substance is excreted by the kidneys.

Indications for admission

According to the instructions for use, Erespal is prescribed for the treatment of infectious and inflammatory diseases of the respiratory organs. The main indications are:

  • SARS, influenza, colds;
  • inflammation in the throat;
  • bronchitis;
  • rhinitis;
  • inflammation of the larynx;
  • tracheobronchitis;
  • pneumonia;
  • bronchial asthma;
  • sinusitis and its varieties;
  • otitis and other diseases accompanied by cough.

In addition, Erespal can be used after surgical interventions on the ENT organs: it significantly reduces tissue swelling, normalizes breathing through the nose, and restores the sense of smell.

The use of the drug in case of serious pathologies of the respiratory organs - pneumonia, pleurisy and other diseases, can facilitate their course and improve the general condition of the patient.

The drug is considered universal: it is used both to mitigate dry cough and wet cough with sputum difficult to separate. However, treatment with Erespal cannot replace antibiotics.

How to take adults

The drug is prescribed before or after a meal in doses depending on the severity of the disease and the age of the patient.

For adults, the medicine is prescribed one tablet two to three times a day.

Chronic inflammatory pathologies require the use of two tablets a day in the morning and evening. With an exacerbation of inflammation, it is recommended to take three pills per day. In addition, a specialist can prescribe an individual treatment regimen for a particular patient.

It is also allowed to take Erespal in syrup for adults. The optimal dosage is 3-6 tablespoons per day.

The highest dosage in 24 hours should not exceed 240 mg. The duration of the course is determined by the attending physician. Most often, it is recommended that adults take Erespal for 7 days.

Clinical trials have established that the positive effect of the drug appears after a week of continuous therapy. In chronic pathologies and pulmonary obstruction, treatment can be extended to several weeks. Thus, an adult can drink Erespal for up to 30 days.

Erespal: compatibility

One of the advantages of the drug is its good compatibility with other drugs - expectorants and antibiotics, so it can be used as part of a combination treatment.

Erespal and alcohol are incompatible: the drug can enhance the sedative effect of ethyl alcohol. For the same reason, the drug is not recommended to be taken in conjunction with sedatives: it can lead to increased drowsiness and decreased performance.

Contraindications and side effects

Fenspiride is a fairly safe substance that allows the use of medicines based on it in pediatric practice. Despite this, the tool has some limitations for reception:

  • hypersensitivity to the active substance;
  • children's age less than 2 years.

Caution in the use of the drug must be observed in adult patients with fructose and sucrose intolerance, as well as those suffering from diabetes mellitus.

You should not treat a child with a pill, dividing it into parts: in childhood, only medicine is used. However, in some situations, syrup is prescribed for adult patients.

It is worth refraining from using Erespal during pregnancy and breastfeeding: there is currently no data on the effect of the drug on a woman and a child.

Usually the drug is easily tolerated and does not provoke side effects. However, in case of individual intolerance, the drug can provoke:

  • abdominal pain;
  • diarrhea
  • nausea;
  • loss of strength, increased fatigue;
  • dizziness;
  • violation of the heart rhythm;
  • skin rash.

When using the drug in an increased dose, overdose symptoms may occur - an increase in heart rate, gag reflexes, overexcitation, or, conversely, weakness. In this case, it is necessary to carry out symptomatic treatment.

Erespal is a really effective drug with a complex effect. In addition to its direct purpose - elimination of cough, the drug has an anti-inflammatory, bronchodilatory, antispasmodic effect, which allows it to be used in the treatment of diseases of various parts of the ENT organs.



Random articles

Up